During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
The experts, the specific content and the informal setting will improve you as a professional.
Brechtje Vreenegoor
Radboud Universteit, Netherlands
Just perfect 3 days full of information and perfect communication.
Petr Kubečka
Palacký University Olomouc, Czech Republic
The event had something to offer all members of the TT community from entry level to mid-career and beyond.
John Gleeson
University of Limerick, Ireland
As always, superb topics and inspirational speakers. Great networking. Well worth the time out of the office!!! Great work HQ, thank you.
Peter Deakin
Chalmers University of Technology, Sweden
There was ample opportunity to learn from colleagues through the workshop sessions or more formally through speakers either sharing their years of experience or their state of the art research. Well worth attending.
John Gleeson
University of Limerick, Ireland
Join our newsletter and get the latest news